Diagnostic hapten-carrier conjugates BSA-Cholyglycine (CG), OVA-Cholyglycine (CG), KLH-Cholyglycine (CG) for Liver diseaseCGdetection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Product Details
Serum Cholyglycine (Cholyglycine, CG) is one of the binding cholic acid combined by cholic acid and glycine, within the liver cells, cholesterol transformed into the primary bile acid through the extremely complex enzymatic reaction. Including cholic acid (CA) and chenodeoxycholic acid (CD – CA). there are three hydroxyl (C3, C7, C12) in the steroid nucleus of cholic acid, the hydroxyl at the end of side chains using peptide bonds with glycine, the molecular weight is 462 u.Genemedi produces core diagnostic ingredients for test of Liver disease and related syndrome.
GeneMedi offers Diagnostic hapten-carrier conjugates BSA-Cholyglycine (CG), OVA-Cholyglycine (CG), KLH-Cholyglycine (CG) for Liver disease CG detection in Competitive immunoassay validation (Competitive ELISA), Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Liver disease test are suitable for in functional ELISA, and other immunoassays in dignostics.
Product Description
|
Cat No.
|
GMP-SMT-CG-Ag-Ab
|
|
Product Name
|
BSA-Cholyglycine (CG) / OVA-Cholyglycine (CG)
|
|
Expression platform
|
Synthetic
|
|
Bioactivity validation
|
Cholyglycine (CG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CG level test of Liver diseases (liver cirrhosis or
obstructive liver disease) and related syndrome evaluation
|
|
Products description
|
Competitive immunoassay-validated hapten-carrier conjugates BSA-Cholyglycine (CG) / OVA-Cholyglycine (CG) is Synthetic.
|
|
Purity
|
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
|
Cat No.
|
GMP-SMT-CG-Ag-Ab
|
|
Product Name
|
Anti-human Cholyglycine (CG) mouse monoclonal antibody (mAb)
|
|
Expression platform
|
Hybridoma
|
|
Isotypes
|
Mouse IgG
|
|
Bioactivity validation
|
Cholyglycine (CG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cholyglycine (CG) antibodies in CG level test of Liver diseases (liver cirrhosis or
obstructive liver disease) and related syndrome evaluation.
|
|
Tag
|
mFc
|
|
Products description
|
Anti-human Cholyglycine (CG) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
|
|
Specics
|
mouse
|
|
Purity
|
Purity: ≥95% （SDS-PAGE）
|
|
Application
|
Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
|
|
Formulation
|
Lyophilized from sterile PBS, PH 7.4
|
|
Storage
|
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
|
Diagnostic antibodies and antigens for Epilepsy-related valproate (VPA) toxicity testing: Sodium valproate (VPA)
Valproate is a commonly used antiepileptic drug for the treatment of epilepsy and seizures. It is safe for use in both adults and children more than three years of age. Valproate toxicity can occur both accidentally and intentionally. Acute valproate overdose usually presents with CNS depression/encephalopathy, electrolyte abnormalities such as hypernatremia, elevated transaminase levels, hyperammonemia, and hepatoxicity. In patients with a severe overdose of valproate, patients can present with hypotension, tachycardia, respiratory depression, metabolic acidosis, cerebral edema, and valproate-related hyperammonemic encephalopathy which may progress to coma and death. GENEMEDI developed the Gastrin-17 (G-17) antigens and antibodies for the diagnosis of valproate toxicity based on ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
